![Edward Gudaitis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward Gudaitis
Amministratore Delegato presso ACERUS PHARMACEUTICALS CORPORATION
Profilo
Edward Gudaitis is currently the President, CEO & Non-Independent Director at Acerus Pharmaceuticals Corp.
He previously worked as Vice President & General Manager at Allergan (Canada) from 2016 to 2018, and as General Manager at Gilead Sciences Canada, Inc. from 2005 to 2016.
Before that, he held director positions at BIOTECanada and Innovative Medicines Canada.
Mr. Gudaitis received an undergraduate degree from Brock University and an MBA from Richard Ivey School of Business.
Posizioni attive di Edward Gudaitis
Società | Posizione | Inizio |
---|---|---|
ACERUS PHARMACEUTICALS CORPORATION | Amministratore Delegato | 01/05/2018 |
Precedenti posizioni note di Edward Gudaitis
Società | Posizione | Fine |
---|---|---|
Allergan (Canada)
![]() Allergan (Canada) Pharmaceuticals: MajorHealth Technology Allergan operates as a pharmaceutical company. The company is headquartered in Unionville, Canada. | Corporate Officer/Principal | 01/04/2018 |
Gilead Sciences Canada, Inc.
![]() Gilead Sciences Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Gilead Sciences, Inc., Gilead Sciences Canada, Inc. operates as a Canadian biopharmaceutical company. The company is based in Mississauga, Canada. | Corporate Officer/Principal | 01/10/2016 |
Innovative Medicines Canada
![]() Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Direttore/Membro del Consiglio | - |
BIOTECanada
![]() BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Direttore/Membro del Consiglio | - |
Formazione di Edward Gudaitis
Brock University | Undergraduate Degree |
Richard Ivey School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
BIOTECanada
![]() BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Innovative Medicines Canada
![]() Innovative Medicines Canada Miscellaneous Commercial ServicesCommercial Services Innovative Medicines Canada manufactures medical and toilet products. The company was founded on April 23, 1914 and is headquartered in Ottawa, Canada. | Commercial Services |
Acerus Pharmaceuticals Corp.
![]() Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
Allergan (Canada)
![]() Allergan (Canada) Pharmaceuticals: MajorHealth Technology Allergan operates as a pharmaceutical company. The company is headquartered in Unionville, Canada. | Health Technology |
Gilead Sciences Canada, Inc.
![]() Gilead Sciences Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Gilead Sciences, Inc., Gilead Sciences Canada, Inc. operates as a Canadian biopharmaceutical company. The company is based in Mississauga, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Edward Gudaitis